R&D Surge Widens Illumina s Q4 Net Loss; Revenue Inches Ahead

Feb 01, 2002

NEW YORK, Feb. 1 - Illumina on Friday said that a significant increase in R&D spending caused it to post widened net losses in the fourth quarter of 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

UW Study Examines Prevalence of Non-Founder BRCA1, BRCA2, Other Mutations in Breast Cancer
Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses
Lean Body Mass Meta-Analysis Leads to New Loci
BioMérieux Q2 Revenues Up 11 Percent, Led by FilmArray Sales
Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library
Novacyt H1 Sales Spike Sharply

The Scan

Skipped Steps

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

Just a Few Bats

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

This Week in Nature

In Nature this week: investigation into the genetics of medulloblastoma, and more.

Genomics for the Trees

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.

Main menu